Stout Jay S
SEC CIK 1702969 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IMVT | Immunovant, Inc. | CTO | 205.3K | — | $2.86M | 21 | 2023-04-17 | 2026-07-23 |
Most active insiders at IMVT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Roivant Sciences Ltd. | Dir, 10% | $350.00M | — |
| 2 | Fromkin Andrew J. | Dir | — | $7.96M |
| 3 | Stout Jay S | CTO | — | $2.27M |
| 4 | Gloria Melanie | COO | — | $1.60M |
| 5 | Girao Tiago | CFO | — | $1.41M |
| 6 | Van Tuyl Christopher | CLO | — | $1.31M |
| 7 | Venker Eric | CEO, Dir | — | $461.8K |
| 8 | Pande Atul | Dir | — | $424.6K |
| 9 | Hughes Douglas J. | Dir | — | $348.7K |
| 10 | Geffner Michael | Chief Medical Off | — | $70.1K |
Transactions 21
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-24 17:57 | 2026-07-23 | IMVT | Immunovant, Inc. | Stout Jay S | CTO | S - Sale | $38.69 | -2,857 | 205.3K | -1% | -$110.5K | |
| M | 2026-07-10 16:12 | 2026-07-08 | IMVT | Immunovant, Inc. | Stout Jay S | CTO | S - Sale | $39.55 | -3,487 | 208.2K | -2% | -$137.9K |
| M | 2026-06-26 19:45 | 2026-06-26 | IMVT | Immunovant, Inc. | Stout Jay S | CTO | S - Sale | $38.31 | -40.0K | 211.7K | -16% | -$1.53M |
| 2026-04-24 16:05 | 2026-04-23 | IMVT | Immunovant, Inc. | Stout Jay S | CTO | S - Sale | $29.62 | -2,754 | 251.7K | -1% | -$81.6K | |
| M | 2026-04-10 16:02 | 2026-04-08 | IMVT | Immunovant, Inc. | Stout Jay S | CTO | S - Sale | $24.83 | -10.1K | 254.4K | -4% | -$251.6K |
| D | 2026-04-09 16:19 | 2026-04-07 | IMVT | Immunovant, Inc. | Stout Jay S | CTO | A - Grant | $0.00 | +66.9K | 264.6K | +34% | $0 |
| 2026-01-23 | 2026-01-21 | IMVT | Immunovant, Inc. | Stout Jay S | CTO | S - Sale | $26.03 | -1,977 | 197.6K | -1.0% | -$51.5K | |
| M | 2026-01-09 | 2026-01-07 | IMVT | Immunovant, Inc. | Stout Jay S | CTO | S - Sale | $26.53 | -1,203 | 199.6K | -0.6% | -$31.9K |
| 2025-10-24 | 2025-10-22 | IMVT | Immunovant, Inc. | Stout Jay S | CTO | S - Sale | $19.03 | -2,520 | 200.8K | -1% | -$48.0K | |
| 2025-10-10 | 2025-10-08 | IMVT | Immunovant, Inc. | Stout Jay S | CTO | S - Sale | $16.30 | -1,585 | 203.3K | -0.8% | -$25.8K | |
| 2025-07-25 | 2025-07-23 | IMVT | Immunovant, Inc. | Stout Jay S | CTO | S - Sale | $18.15 | -2,805 | 204.9K | -1% | -$50.9K | |
| 2025-07-11 | 2025-07-09 | IMVT | Immunovant, Inc. | Stout Jay S | CTO | S - Sale | $17.24 | -1,519 | 207.7K | -0.7% | -$26.2K | |
| 2025-04-25 | 2025-04-23 | IMVT | Immunovant, Inc. | Stout Jay S | CTO | S - Sale | $14.79 | -1,925 | 209.2K | -0.9% | -$28.5K | |
| 2025-04-11 | 2025-04-09 | IMVT | Immunovant, Inc. | Stout Jay S | CTO | S - Sale | $12.99 | -5,004 | 211.2K | -2% | -$65.0K | |
| D | 2025-04-03 | 2025-04-01 | IMVT | Immunovant, Inc. | Stout Jay S | CTO | A - Grant | $0.00 | +76.2K | 216.2K | +54% | $0 |
| 2025-01-24 | 2025-01-22 | IMVT | Immunovant, Inc. | Stout Jay S | CTO | S - Sale | $23.59 | -2,195 | 140.0K | -2% | -$51.8K | |
| 2024-10-25 | 2024-10-23 | IMVT | Immunovant, Inc. | Stout Jay S | CTO | S - Sale | $29.53 | -2,740 | 142.2K | -2% | -$80.9K | |
| 2024-07-26 | 2024-07-24 | IMVT | Immunovant, Inc. | Stout Jay S | CTO | S - Sale | $27.76 | -2,813 | 144.9K | -2% | -$78.1K | |
| 2024-04-26 | 2024-04-24 | IMVT | Immunovant, Inc. | Stout Jay S | CTO | S - Sale | $28.90 | -7,239 | 147.7K | -5% | -$209.2K | |
| D | 2024-04-04 | 2024-04-02 | IMVT | Immunovant, Inc. | Stout Jay S | CTO | A - Grant | $0.00 | +55.0K | 155.0K | +55% | $0 |
| D | 2023-04-19 | 2023-04-17 | IMVT | Immunovant, Inc. | Stout Jay S | CTO | A - Grant | $0.00 | +100.0K | 100.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations